T. Rowe Price Associates Portfolio holdings
T. Rowe Price Associates, Inc., founded in 1937 by Thomas Rowe Price, Jr., is a globally recognized investment management firm headquartered in Baltimore, Maryland, known for its disciplined, research-driven approach to active investing. The company manages hundreds of billions in assets, offering a wide range of mutual funds, retirement plans, and advisory services tailored to individual investors, institutions, and financial intermediaries. Emphasizing long-term growth and a conservative investment philosophy, T. Rowe Price has built a strong reputation for its equity and fixed-income funds, often focusing on fundamental analysis to identify undervalued opportunities. Still publicly traded and independent, it remains a trusted name in the industry, balancing tradition with innovation to meet evolving client needs.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Becton Dickinson
BDX
|
+$3.46B |
| 2 |
UnitedHealth
UNH
|
+$2.79B |
| 3 |
Salesforce
CRM
|
+$2.38B |
| 4 |
Sherwin-Williams
SHW
|
+$1.41B |
| 5 |
Philip Morris
PM
|
+$1.34B |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Meta Platforms (Facebook)
META
|
+$4.44B |
| 2 |
Alphabet (Google) Class C
GOOG
|
+$2.97B |
| 3 |
GE Aerospace
GE
|
+$2.3B |
| 4 |
HCA Healthcare
HCA
|
+$2.17B |
| 5 |
American International
AIG
|
+$1.68B |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 26.68% |
| 2 | Healthcare | 19.49% |
| 3 | Consumer Discretionary | 13.07% |
| 4 | Financials | 11.18% |
| 5 | Communication Services | 8.7% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
1876
AeroVironment
AVAV
$9.73B
| $1.03M | ﹤0.01% |
12,500
-184
| -1% | -$16.3K |
|
1877
Frontdoor
FTDR
$5.94B
| $1.02M | ﹤0.01% |
42,563
+4,330
| +11% | +$117K |
|
|
GCP
1878
DELISTED
GCP Applied Technologies Inc.
GCP
| $1.02M | ﹤0.01% |
32,747
-10,960
| -25% | -$342K |
|
1879
Viasat
VSAT
$11.2B
| $1.02M | ﹤0.01% |
33,321
+638
| +2% | +$24.7K |
|
1880
California Resources
CRC
$4.75B
| $1.02M | ﹤0.01% |
26,464
+6,012
| +29% | +$258K |
|
1881
QuantumScape Corp
QS
$3.8B
| $1.02M | ﹤0.01% |
118,330
+5,141
| +5% | +$68.6K |
|
1882
Crinetics Pharmaceuticals
CRNX
$8.98B
| $1.01M | ﹤0.01% |
54,407
+16,824
| +45% | +$336K |
|
1883
Donnelley Financial Solutions
DFIN
$1.21B
| $1.01M | ﹤0.01% |
34,668
-39
| -0.1% | -$1.16K |
|
1884
V2X
VVX
$2.6B
| $1.01M | ﹤0.01% |
30,348
+93
| +0.3% | +$3.29K |
|
1885
Ennis
EBF
$559M
| $1.01M | ﹤0.01% |
50,094
-23,381
| -32% | -$421K |
|
1886
LiveRamp
RAMP
$2.31B
| $1.01M | ﹤0.01% |
39,016
+1,463
| +4% | +$43.4K |
|
1887
First Financial Bancorp
FFBC
$3.61B
| $1M | ﹤0.01% |
51,722
+658
| +1% | +$13.7K |
|
|
ARI
1888
Apollo Commercial Real Estate
ARI
$887M
| $997K | ﹤0.01% |
95,506
+2,346
| +3% | +$28.8K |
|
1889
Cenovus Energy
CVE
$57.7B
| $997K | ﹤0.01% |
52,524
+1,270
| +2% | +$25.3K |
|
1890
Boise Cascade
BCC
$2.91B
| $992K | ﹤0.01% |
16,676
+5,696
| +52% | +$420K |
|
1891
Vertiv
VRT
$112B
| $990K | ﹤0.01% |
120,413
-469
| -0.4% | -$5.31K |
|
|
LUMO
1892
DELISTED
Lumos Pharma, Inc. Common Stock
LUMO
| $986K | ﹤0.01% |
127,994
-31,601
| -20% | -$253K |
|
1893
Valaris
VAL
$6.02B
| $985K | ﹤0.01% |
23,312
+8,412
| +56% | +$453K |
|
1894
Q2 Holdings
QTWO
$4.06B
| $981K | ﹤0.01% |
25,435
+1,022
| +4% | +$49.7K |
|
1895
BOK Financial
BOKF
$8.87B
| $978K | ﹤0.01% |
12,944
-13,137
| -50% | -$1.11M |
|
1896
National Health Investors
NHI
$3.58B
| $978K | ﹤0.01% |
16,136
-13,966
| -46% | -$795K |
|
1897
Cathay General Bancorp
CATY
$4.33B
| $972K | ﹤0.01% |
24,826
+361
| +1% | +$14.7K |
|
1898
Chegg
CHGG
$88.4M
| $972K | ﹤0.01% |
51,770
+5,768
| +13% | +$132K |
|
1899
Globalstar
GSAT
$10.6B
| $972K | ﹤0.01% |
52,706
+13,012
| +33% | +$241K |
|
1900
Zillow
ZG
$7.93B
| $971K | ﹤0.01% |
30,520
+1,946
| +7% | +$76.8K |
|
Similar funds
T. Rowe Price Associates's Q2 2022 Portfolio in Review
As of Q2 2022, T. Rowe Price Associates held 3,063 positions worth $791B, down 20% from $992B the previous quarter. Its ten largest holdings account for 26% of the portfolio.
T. Rowe Price Associates's Q2 2022 filing shows 88 new, 1,490 increased, 1,207 reduced and 101 closed positions. Its largest new stake was ESAB: 6,073,363 shares worth $266M. The largest sale was Meta Platforms (Facebook), an estimated $4.44B.
By sector, the portfolio is most concentrated in Technology at 27% of assets, down from 27% a quarter earlier, followed by Healthcare and Consumer Discretionary.
- T. Rowe Price Associates's largest Q2 2022 buy was ESAB: 6,073,363 shares worth $266M.
- T. Rowe Price Associates added most to Becton Dickinson in Q2 2022, an estimated $3.46B increase.
- T. Rowe Price Associates's biggest Q2 2022 reduction was Meta Platforms (Facebook), cutting an estimated $4.44B.
- T. Rowe Price Associates fully exited Ortho Clinical Diagnostics Holdings plc Ordinary Shares in Q2 2022, selling an estimated $364M.
- T. Rowe Price Associates's ten largest holdings make up 26% of its $791B portfolio in Q2 2022.
- T. Rowe Price Associates opened 88 new positions and closed 101 in Q2 2022.
- T. Rowe Price Associates's portfolio value fell 20% quarter-over-quarter to $791B.
Based on T. Rowe Price Associates's 13F filing for Q2 2022, filed 15 Aug 2022.